Leaderboard

En | De
No articles selected!     View Cart  
You are here: Neurology » Multiple Sclerosis 03. April 2026
Search
medline.ch
Multiple Sclerosis
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 2184  Previews Next
   
   Articles 1 - 20 / 43671  
   
Infection Risk and Vaccine Considerations in Multiple Sclerosis and Related Disorders.
Continuum (Minneap Minn)
Nath A, Bar-Or A.
PMID: 41925513 [PubMed - indexed for MEDLINE]


Diagnosis of Multiple Sclerosis.
Continuum (Minneap Minn)
Arrambide G, Lebrun-Frénay C.
PMID: 41925511 [PubMed - indexed for MEDLINE]


Treatment of Multiple Sclerosis.
Continuum (Minneap Minn)
Mowry EM, Okuda DT, Ontaneda D.
PMID: 41925508 [PubMed - indexed for MEDLINE]


Palliative Care in Multiple Sclerosis.
Continuum (Minneap Minn)
Smyth P, Miyasaki JM.
PMID: 41925504 [PubMed - indexed for MEDLINE]


Adult-Onset Leukodystrophies Mimicking Multiple Sclerosis.
Continuum (Minneap Minn)
Macaron G, La Piana R.
PMID: 41925503 [PubMed - indexed for MEDLINE]


Diagnostic Approach to Presumptive Demyelinating Solitary CNS Lesions.
Continuum (Minneap Minn)
Hardy TA.
PMID: 41925502 [PubMed - indexed for MEDLINE]


Diagnostic Neuroimaging Biomarkers for Multiple Sclerosis.
Continuum (Minneap Minn)
Oh J.
PMID: 41925498 [PubMed - indexed for MEDLINE]


Family Planning in Neuroinflammatory Disease.
Continuum (Minneap Minn)
Dobson R, Hellwig K.
PMID: 41925496 [PubMed - indexed for MEDLINE]


Clinical relevance and predictors of anti-natalizumab antibodies in multiple sclerosis: A real-world retrospective cohort study.
Mult Scler J Exp Transl Clin
Levy M, Beigneux Y, Roux T, Mossad M, Ricigliano V, Senant M, Papeix C, Stankoff B, Louapre C, Maillart E, Lazzarotto A.
PMID: 41924393 [PubMed]


Cross-sectional brain volumetric measures and disability outcomes in relapsing-remitting multiple sclerosis.
J Neurol
Hayes MTG, Beadnall HN, Merlo D, Monif M, Zhu C, Barnett M, Buzzard K, Horakova D, Kalincik T, Laureys G, Lui E, Lechner-Scott J, Nguyen AL, Patti F, Sima DM, Smeets D, Vaneckova M, Van Hecke W, Van Pesch V, van der Walt A, Butzkueven H.
PMID: 41922867 [PubMed - indexed for MEDLINE]


Updates on the Acute and Maintenance Management of Optic Neuritis Including Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Glycoprotein Antibody Disease.
Neurol Clin
Alchaki AR.
PMID: 41922028 [PubMed - indexed for MEDLINE]


Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS.
Neurology
Tournier A, Gavoille A, Pique J, Levraut M, Micoud E, Maillart E, Audoin B, Demortiere S, Boutiere C, Ayrignac X, Boucraut J, Jentzer A, Ciron J, Bost C, Collongues N, Deschamps R, Cohen M, Seitz-Polski B, Thouvenot E, Squalli S, Maréchal D, Branger P, Ahle G, Zephir H, Vukusic S, Klapczynski F, Laplaud DA, Giannesini C, Mélé N, Drouet T, Sterlin D, Marignier R.
PMID: 41921124 [PubMed - indexed for MEDLINE]


Reliability of a convolutional neural network in segmenting multiple sclerosis lesions from MRI: Impact of data augmentation, image modality and tolerance with U-Net architecture.
PLOS Digit Health
Szekely-Kohn AC, Castellani M, Baronti L, Ahmed Z, Manifold WGK, Douglas M, Espino DM.
PMID: 41920815 [PubMed]


Why Is MS a More Frequent Complication of EBV Infection in Females?
Immunol Rev
Dunn SE, Alvarez-Sanchez N, Steinman L.
PMID: 41919465 [PubMed - indexed for MEDLINE]


The Kappa Free Light Chains Index in Multiple Sclerosis: From Emerging Evidence to Clinical Application.
J Neurochem
Verchere N, Roult S, Michel L, Le Page E, Rousseau C, Messaoudi K, Hasbini R, Bendavid C, Dumontet E, Moreau C.
PMID: 41919443 [PubMed - indexed for MEDLINE]


Economic value of anti-CD20 therapies in multiple sclerosis: a systematic review of cost-effectiveness studies.
Ther Adv Neurol Disord
Heinemann J, Zirkel M, Schoeffski O, Dersch R, Wiendl H.
PMID: 41919071 [PubMed]


The cytokine signature in multiple sclerosis: a study during the SARS-CoV-2 pandemic.
Front Immunol
Puthenparampil M, Marin A, De Napoli F, Di Paola A, Mauceri AV, Ruggero S, Rinaldi F, Perini P, Viola A, Molon B, Gallo P.
PMID: 41918744 [PubMed - indexed for MEDLINE]


Efficacy and safety of disease-modifying oral drugs in treatment of relapsing-remitting multiple sclerosis: systematic review and network meta-analysis.
Front Immunol
Zhao Y, Chen B, Zhao X, Yang R, He W, Li D, Sun Q, Zhang J, Liu X.
PMID: 41918730 [PubMed - indexed for MEDLINE]


Regulation and Interaction Among SOCS1 and SOCS3 by MicroRNAs in Multiple Sclerosis: A Review and In Silico Analysis.
Yale J Biol Med
Gallardo-Pérez MM, Garcés-Eisele SJ, Madrazo-Cabo JM, Sedeño-Monge V.
PMID: 41918507 [PubMed - indexed for MEDLINE]


Genetic Influences on Disease-Modifying Therapy Response in Multiple Sclerosis: Current Insights and Future Directions.
Balkan Med J
Reda MD, Siva A, Tahir Turanl.
PMID: 41918263 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 43671    Page 1 of 2184  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1